N22245
yw34g08.s1 Morton Fetal Cochlea Homo sapiens cDNA clone IMAGE:254174 3' similar to gb:M64241 QM PROTEIN (HUMAN), mRNA sequence.
280
mRNA
Homo sapiens
LF829401
JP 2016528161-A/22234: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
LV568067
JP 2017029159-A/22245: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DM758939
JP 2014079248-A/22245: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
FU796726
JP 2009528046-A/22243: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
DD548848
JP 2004508801-A/22245: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
DJ526045
JP 2010517930-A/22245: Method of constructing and screening libraries of peptide structures.
30
PRT
synthetic construct
DJ151625
JP 2007228956-A/22243: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
PA337893
JP 2021522188-A/22245: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
DL612847
JP 2011092200-A/22245: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
MC774355
JP 2018525446-A/22245: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
32
PRT
synthetic construct
PA526729
JP 2022502046-A/9511: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
OG751764
JP 2021120380-A/22245: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
MD754487
JP 2019507579-A/22245: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
MC164089
JP 2019500349-A/22245: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
LX119861
JP 2017506877-A/22243: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
HZ527026
JP 2016501039-A/22245: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
LF681466
JP 2016521556-A/22245: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
HW857469
JP 2015051004-A/22197: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
MD268378
JP 2020517247-A/22245: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
DM796703
JP 2014068652-A/22245: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
HV878786
JP 2010507387-A/22197: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
DL031259
JP 2005512499-A/22245: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
822
DNA
synthetic construct
PA392968
JP 2021533803-A/22051: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
MC550745
JP 2019525738-A/22245: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
118
PRT
synthetic construct
MB811503
JP 2019502674-A/22245: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
36
PRT
synthetic construct
DL903989
JP 2014205669-A/22245: Method of constructing and screening libraries of peptide structures.
30
PRT
synthetic construct
HW187273
JP 2013102767-A/22197: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DJ952606
JP 2010500568-A/39287: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE.
1258
PRT
Homo sapiens
DD802515
JP 2008525033-A/22245: Group B Streptococcus.
831
PRT
Streptococcus agalactiae